Page last updated: 2024-11-05

thalidomide and Primary Peritonitis

thalidomide has been researched along with Primary Peritonitis in 3 studies

Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.

Research Excerpts

ExcerptRelevanceReference
"Thalidomide was administered orally at a dose of 100 mg/kg three times per week."5.35Thalidomide suppresses sclerosing encapsulating peritonitis in a rat experimental model. ( Aloisi, C; Buemi, M; Crisafulli, C; Cuzzocrea, S; Di Paola, R; Mazzon, E; Mondello, P; Mondello, S, 2009)
"Thalidomide was administered orally at a dose of 100 mg/kg three times per week."1.35Thalidomide suppresses sclerosing encapsulating peritonitis in a rat experimental model. ( Aloisi, C; Buemi, M; Crisafulli, C; Cuzzocrea, S; Di Paola, R; Mazzon, E; Mondello, P; Mondello, S, 2009)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
da Silva, YK1
Augusto, CV1
de Castro Barbosa, ML1
de Albuquerque Melo, GM1
de Queiroz, AC1
de Lima Matos Freire Dias, T1
JĂșnior, WB1
Barreiro, EJ1
Lima, LM2
Alexandre-Moreira, MS2
Mondello, S1
Mazzon, E1
Di Paola, R1
Crisafulli, C1
Mondello, P1
Buemi, M1
Aloisi, C1
Cuzzocrea, S1
dos Santos, JL1
Lanaro, C1
Gambero, S1
Franco-Penteado, CF1
Wade, M1
Yerigenahally, S1
Kutlar, A1
Meiler, SE1
Costa, FF1
Chung, M1

Other Studies

3 other studies available for thalidomide and Primary Peritonitis

ArticleYear
Synthesis and pharmacological evaluation of pyrazine N-acylhydrazone derivatives designed as novel analgesic and anti-inflammatory drug candidates.
    Bioorganic & medicinal chemistry, 2010, Jul-15, Volume: 18, Issue:14

    Topics: Analgesics; Animals; Anti-Inflammatory Agents; Arthritis; Ear; Edema; Female; Freund's Adjuvant; Hyd

2010
Thalidomide suppresses sclerosing encapsulating peritonitis in a rat experimental model.
    Shock (Augusta, Ga.), 2009, Volume: 32, Issue:3

    Topics: Animals; Anti-Infective Agents; Blotting, Western; Chlorhexidine; Disease Models, Animal; Enzyme Act

2009
Design, synthesis, and pharmacological evaluation of novel hybrid compounds to treat sickle cell disease symptoms.
    Journal of medicinal chemistry, 2011, Aug-25, Volume: 54, Issue:16

    Topics: Acetic Acid; Analgesics; Anemia, Sickle Cell; Animals; Anti-Inflammatory Agents; Antisickling Agents

2011